The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
Open accessAbstract
This study examined androgen receptor (AR) gene amplification and protein expression in 102 matched paired hormone sensitive and resistant tumours from 51 patients. AR gene amplification and X chromosome copy number were assessed by fluorescent in situ hybridisation, and protein expression was assessed by immunohistochemistry. All tumours were stained for PSA protein expression. Significantly more tumours exhibited AR amplification following the development of hormone resistance (20%, 10 out of 49) compared to matched hormone-sensitive tumours from the same patient (2%, one out of 48) (P=0.0085). The level of AR expression was significantly higher in hormone-resistant tumours compared to matched hormone-sensitive tumours from the same patient (130, interquartile range, 55-167 vs 94.5 interquartile range, 55-120, P=0.019). AR expression levels in hormone-resistant tumours with and without AR amplification were not significantly different. However, an increase in AR expression was seen with the development of AR amplification in paired tumours. The rate of AR gene amplification and/or an increase in AR protein expression during androgen resistant is too low to wholly explain the development of androgen resistance. Alternative mechanisms for modulating the function of the AR, or other signalling pathways, must be considered as key factors in the development of hormone-resistant prostate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Medical Research.
Armitage, P. (1972) · Biometrics · doi:10.2307/2556182 · Cited by 4,029
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484 · cited 4×
“The mechanisms involved with the development of resistance are poorly understood, but AR mutations (Avila et al, 2001), AR amplification (Visakorpi et al, 1995), increased AR expression (Gregory et al, 1998) and activation of the AR by interaction with other signalling pathways have been implicated…”
BackgroundInfluentialAmplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
Linja, M. J., Savinainen, K., Saramäki, O. R., Tammela, T. L. J., Vessella, R. L., & Visakorpi, T. (2001) · PubMed · Cited by 774
Koivisto, P. A., Kononen, J., Palmberg, C., Tammela, T. L. J., HYYTINEN, E.-R., Isola, J. J., Trapman, J., Cleutjens, K. B. J. M., Noordzij, M. A., Visakorpi, T., et al. (1997) · PubMed · Cited by 728
Bubendorf, L., Kononen, J., Koivisto, P. A., Schraml, P., Moch, H., Gasser, T. C., Willi, N., Mihatsch, M. J., Sauter, G., & Kallioniemi, O. (1999) · PubMed · Cited by 594
Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.
Lin, H.-K., Yeh, S., Kang, H.-Y., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121173298 · Cited by 401
Gregory, C. W., Hamil, K. G., Kim, D., Hall, S. H., Pretlow, T. G., Mohler, J. L., & French, F. S. (1998) · PubMed · Cited by 306
Latil, A., Bièche, I., Vidaud, D., Lidereau, R., Berthon, P., Cussenot, O., & Vidaud, M. (2001) · PubMed · Cited by 239
Expression, structure, and function of androgen receptor in advanced prostatic carcinoma
Čulig, Z., Hobisch, A., Hittmair, A., Peterziel, H., Cato, A. C. B., Bartsch, G. C., & Klocker, H. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980401)35:1<63::aid-pros9>3.0.co;2-i · Cited by 151
Segawa, N., Mori, I., Utsunomiya, H., Nakamura, M., Nakamura, Y., Shan, L., Kakudo, K., & Katsuoka, Y. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01226.x · Cited by 87
Androgen-regulated gene expression in prostate cancer
Trapman, J., & Cleutjens, K. B. J. M. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0050 · Cited by 85
Miyoshi, Y., Uemura, H., Fujinami, K., Mikata, K., Harada, M., Kitamura, H., Koizumi, Y., & Kubota, Y. (2000) · The Prostate · Cited by 71
The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer
Avila, D. M., ZOPPI, S., & McPhaul, M. J. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00158-8 · Cited by 59
A role for BRCA1 in sporadic breast cancer
Fraser, J. A., Reeves, J., Stanton, P. D., Black, D. M., Going, J. J., Cooke, T., & Bartlett, J. M. S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600863 · Cited by 58
Self-citationKoivisto, P. A., & Helin, H. J. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199910)189:2<219::aid-path423>3.0.co;2-f · Cited by 48
Edwards, J., Krishna, N. S., Mukherjee, R., Watters, A. D., Underwood, M. A., & Bartlett, J. M. S. (2001) · British Journal of Urology · doi:10.1046/j.1464-410x.2001.02350.x · Cited by 45
Self-citationHenttu, P. M. A., & Vihko, P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8238 · Cited by 39
Steroid-independent activation of androgen receptor in androgen-independent prostate cancer
Zhu, X., & Liu, J. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00168-8 · Cited by 33
Assessment of hormone refractory prostate cancer
Newling, D. W. W., Fosså, S. D., Andersson, L., Abrahamsson, P.-A., Aso, Y., Eisenberger, M. A., Khoury, S., Kozlowsky, J., Kelly, K., Scher, H. I., et al. (1997) · Urology · doi:10.1016/s0090-4295(99)80323-9 · Cited by 27
Research works printed but not linked: 3
- Gnanapragasam VJ, Robson CN, Neal DE, Leung HY (2002) Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene 21: 5069–5080 · doi:10.1038/sj.onc.1205663
- Goktas S, Ziada A, Crawford ED (1999) Combined androgen blockade for advanced prostatic carcinoma. Prostate Cancer Prostatic Dis 2: 172–179 · doi:10.1038/sj.pcan.4500323
- Krishna NS, Edwards J, Underwood MA, Grigor KM, Bartlett JMS (2002) AP-1 as a mediator of androgen refractory prostate cancer. Br J Cancer 86: s34 · doi:10.1038/sj.bjc.6600373
Cited by
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
“This finding is likely to have clinical relevance, based on surveys of androgen receptor levels in patient materia”
BackgroundMontgomery, R. B., Mostaghel, E. A., Vessella, R., Hess, D. L., Kalhorn, T. F., Higano, C. S., True, L. D., & Nelson, P. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0249 · Cited by 1,419
Molecular genetics of prostate cancer: new prospects for old challenges
Shen, M. M., & Abate-Shen, C. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 946
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
Karantanos, T., Corn, P. G., & Thompson, T. C. (2013) · Oncogene · doi:10.1038/onc.2013.206 · Cited by 866
Metadata
- Authors
- Edwards, J., Krishna, N. S., Grigor, K. M., & Bartlett, J. M. S.
- Venue
- British Journal of Cancer
- Published
- 2003-07-29
- Volume
- 89
- Issue
- 3
- Pages
- 552-556
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2024432096
- Cited by
- 424
- References
- 19
- FWCI
- 17.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.